{
  "id": 1410,
  "text": "Comparing radiotherapy with chemoradiotherapy with high-dose-rate brachytherapy, the pooled analysis published by Mayadev et al.1259 (eighty studies11,98,114,1238,1239,1246,1260-1335) reported an improvement in pelvic control and DFS in favour of chemoradiotherapy with highdose-rate brachytherapy whereas the OS of the groups were similar, whatever the study type taken into account: Prospective studies: pelvic control: $8 1 .",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Comparing radiotherapy with chemoradiotherapy with high-dose-rate brachytherapy, the pooled analysis published by Mayadev et al.1259 (eighty studies11,98,114,1238,1239,1246,1260-1335) reported an improvement in pelvic control and DFS in favour of chemoradiotherapy with highdose-rate brachytherapy whereas the OS of the groups were similar, whatever the study type taken into account: Prospective stu\n\n<question>: ",
  "ChatGPT_response_0": "根据Mayadev等人发表的综合分析，优势化疗放疗与高剂量率近距离放疗在盆腔控制和无病生存方面得到了改善，而整体生存率相似。在治疗过程中，我更倾向于选择优势化疗放疗与高剂量率近距离放疗的方案，因为这在盆腔控制和无病生存方面表现更好。整体生存率相似意味着这两种方案在延长患者生存方面没有明显区别。因此，根据病情和患者个体差异，医生会根据具体情况来选择最合适的治疗方案。",
  "query": "在放疗，化疗放疗和高剂量率近距离放疗之间进行比较时，根据Mayadev等人发表的综合分析（80项研究），对于优势化疗放疗与高剂量率近距离放疗，在盆腔控制和无病生存方面得到了改善，而各组的整体生存率则相似。您在治疗过程中更倾向于选择哪种方案？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在放疗，化疗放疗和高剂量率近距离放疗之间进行比较时，根据Mayadev等人发表的综合分析（80项研究），对于优势化疗放疗与高剂量率近距离放疗，在盆腔控制和无病生存方面得到了改善，而各组的整体生存率则相似。您在治疗过程中更倾向于选择哪种方案？\n\n<reference text>: Comparing radiotherapy with chemoradiotherapy with high-dose-rate brachytherapy, the pooled analysis published by Mayadev et al.1259 (eighty studies11,98,114,1238,1239,1246,1260-1335) reported an improvement in pelvic control and DFS in favour of chemoradiotherapy with highdose-rate brachytherapy whereas the OS of the groups were similar, whatever the study type taken into account: Prospective studies: pelvic control: $8 1 .\n\n<reply>: ",
  "response": "根据Mayadev等人发表的综合分析，优势化疗放疗与高剂量率近距离放疗在盆腔控制和无病生存方面得到了改善，而整体生存率相似。在治疗过程中，我更倾向于选择优势化疗放疗与高剂量率近距离放疗的方案，因为这在盆腔控制和无病生存方面表现更好。整体生存率相似意味着这两种方案在延长患者生存方面没有明显区别。因此，根据病情和患者个体差异，医生会根据具体情况来选择最合适的治疗方案。"
}